Loading provider…
Loading provider…
Rheumatology Physician in Houston, TX
NPI: 1538252374Primary Practice Location
Rheumatology Clinic of Houston, PA
11307 Farm To Market Rd 1960, Houston, TX
Primary Employer
Rheumatology Clinic of Houston, PA
houstonrheumatology.com
HQ Phone
Get MD Qaiser's Phone Numberphone_androidMobile
Get MD Qaiser's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
CA State Medical License
1998
TX State Medical License
2006 - 2026
MI State Medical License
1997 - 1998
University of Texas Health Science Center at Houston
Residency • Internal Medicine
1995 - 1998
Aga Khan Medical College
Medical School
Until 1993
UCSF School of Medicine
medschool.ucsf.edu
Fellowship • Rheumatology
1998 - 2001
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 342 | 824 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 300 | 493 |
| 3 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 140 | 226 |
| 4 | J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 135 | 664 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 98 | 98 |
Bone loss: Therapeutic approaches for preventing bone loss in inflammatory arthritis
When to try COX-2-specific inhibitors. Safer than standard NSAIDs in some situations.
Authors: Kenneth Sack
Journal: Postgrad Med
Authors: Nancy Lane, Joel Kremer
Journal: J Rheumatol
Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Intervention / Treatment: DRUG: Parathyroid hormone (hPTH 1-34)
Lead Sponsor: Eli Lilly and Company
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: TNF Inhibitor, DRUG: Baricitinib